Company Filing History:
1 out of 2,202 
1 out of 1,217 
Years Active: 1991-1994
Title: The Innovative Contributions of Anne Hosmalin
Introduction
Anne Hosmalin is a prominent inventor based in Bethesda, MD (US). She has made significant contributions to the field of immunology, particularly in the development of peptides aimed at combating HIV. With a total of 2 patents, her work has the potential to impact the treatment and prevention of HIV infections.
Latest Patents
One of her latest patents is titled "Peptides stimulating cytotoxic T cells immune to HIV RT." This invention relates to a peptide with the amino acid sequence Glu-Ile-Cys-Thr-Glu-Met-Glu-Lys-Glu-Gly-Lys-Ile-Ser-Lys-Ile-Gly-Pro or portions thereof. The peptide is derived from a conserved epitope of HIV-1 reverse transcriptase and may be utilized in treating patients with human immunodeficiency virus or preventing infection in those exposed to the disease. The preparation containing the peptide can be administered subcutaneously, intramuscularly, or intravenously. Another significant patent is for a "Synthetic vaccine against AIDS virus," which involves peptide antigens that stimulate helper T lymphocytes to recognize HIV envelope protein. This enhances antibody production and cytotoxic T cells to inhibit HIV infection.
Career Highlights
Throughout her career, Anne has worked with notable organizations, including the United States of America as represented by the Secretary of Health and the Department of Health. Her innovative work has positioned her as a key figure in the fight against HIV.
Collaborations
Anne has collaborated with esteemed colleagues such as Jay A Berzofsky and Paula M Hale. Their combined expertise has contributed to advancing research in HIV treatment and prevention.
Conclusion
Anne Hosmalin's contributions to immunology and her innovative patents demonstrate her commitment to addressing critical health challenges. Her work continues to inspire advancements in the fight against HIV.